Alliance Pharma (LON:APH) Stock Crosses Above 200 Day Moving Average - Time to Sell?

Alliance Pharma plc (LON:APH - Get Free Report)'s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 52.26 ($0.67) and traded as high as GBX 64.50 ($0.83). Alliance Pharma shares last traded at GBX 64.20 ($0.83), with a volume of 476,889 shares.

Wall Street Analyst Weigh In

Separately, Berenberg Bank lowered shares of Alliance Pharma to a "hold" rating and reduced their price target for the company from GBX 7,000 ($90.30) to GBX 6,250 ($80.62) in a research report on Wednesday, January 29th.

Alliance Pharma Stock Up 0.2 %

The stock's 50-day moving average price is GBX 62.45 and its two-hundred day moving average price is GBX 52.34. The company has a current ratio of 2.93, a quick ratio of 1.42 and a debt-to-equity ratio of 46.27. The stock has a market capitalization of £348.29 million, a P/E ratio of -10.37, a P/E/G ratio of 1.04 and a beta of 0.67.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.